The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Immunosuppression medications for the pediatric patient with a kidney transplant require the nephrology nurse to have a strong foundation in dosing, monitoring and side effects for optimal patient management. This webinar will cover the common immunosuppressive medications utilized for induction and maintenance, along with clinical pearls that the nephrology nurse can take away to improve their knowledge base and improve patient care.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 2/24/24.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure: There are no speaker disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: The American Nephrology Nurses Association (ANNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome: Upon completion of this activity the learner will have an increased depth of knowledge about common immunosuppressive medications used in pediatric transplant patients.